Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
New England Journal of Medicine · 21.08.2025 · 393 (8) · 741-752
DOI: 10.1056/nejmoa2502931 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 21.08.2025. Verfasst von Patrick M Forde und 27 weiteren Autor:innen. Beteiligte Einrichtung: Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 283-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Bristol-Myers Squibb.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin.
- McGill University Health Centre, Montreal.
- Hospital Universitario Puerta de Hierro, Madrid.
- Kindai University Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.
- Memorial Sloan Kettering Cancer Center, New York.
- Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
ORCID-Profile: Patrick M Forde
Förderung
- Bristol-Myers Squibb
Zitieren
APA
Forde, P. M., Spicer, J. D., Provencio, M., Mitsudomi, T., Awad, M. M., Wang, C., Lu, S., Felip, E., Swanson, S. J., Brahmer, J. R., Kerr, K., Taube, J. M., Ciuleanu, T. E., Tanaka, F., Saylors, G. B., Chen, K. N., Ito, H., Liberman, M., Martin, C., …, & CheckMate 816 Investigators (2025). Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. New England Journal of Medicine, 393(8), 741-752. https://doi.org/10.1056/nejmoa2502931
Vancouver
Forde PM, Spicer JD, Provencio M, Mitsudomi T, Awad MM, Wang C, et al. Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer. New England Journal of Medicine. 2025;393(8):741-752. doi:10.1056/nejmoa2502931
BibTeX
@article{Forde2025,
author = {Forde, Patrick M and Spicer, Jonathan D and Provencio, Mariano and Mitsudomi, Tetsuya and Awad, Mark M and Wang, Changli and Lu, Shun and Felip, Enriqueta and Swanson, Scott J and Brahmer, Julie R and Kerr, Keith and Taube, Janis M and Ciuleanu, Tudor-Eliade and Tanaka, Fumihiro and Saylors, Gene B and Chen, Ke-Neng and Ito, Hiroyuki and Liberman, Moishe and Martin, Claudio and Broderick, Stephen and Wang, Lily and Cai, Junliang and Duong, Quyen and Meadows-Shropshire, Stephanie and Fiore, Joseph and Bhatia, Sumeena and Girard, Nicolas and CheckMate 816 Investigators, CheckMate 816 Investigators},
title = {Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {8},
pages = {741--752},
doi = {10.1056/nejmoa2502931}
}
EUVIMED